Health Canada drug identification number

DIN 00282081 — LANVIS 40 MG

LANVIS is a tablet of Thioguanine marketed by ASPEN PHARMACARE CANADA INC.. The full Thioguanine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00282081
Brand name
LANVIS
Active ingredient
Thioguanine
Strength
40 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
ASPEN PHARMACARE CANADA INC.
Health Canada status
MARKETED
Drug class
Antineoplastic agent (purine analogue antimetabolite / thiopurine)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.